Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usability of Placebo ELLIPTA Inhaler in COPD
NCT02586493Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial, sponsored by GSK. Primary endpoint: Percentage of Participants With COPD Who Rate the Use of the ELLIPTA Inhaler as Easy or Very Easy at Day 30. Started Oct 2015; status: completed.
Beyond the preview
Go deeper on NCT02586493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586493.